(Q40260742)

English

Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials

scientific article published on March 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23324563%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23324563%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

based on heuristic

inferred from title

Susanna Esposito

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23324563%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23324563%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Daniela Toneatto

6

object named as

Daniela Toneatto

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23324563%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Timo Vesikari

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23324563%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Ellen Ypma

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23324563%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Igor Kohl

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23324563%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Peter Dull

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23324563%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Alan Kimura

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23324563%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

EU Meningococcal B Infant Vaccine Study group

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23324563%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

language of work or name

0 references

publication date

1 March 2013

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23324563%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23324563%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

381

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23324563%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

9869

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23324563%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

825-835

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23324563%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Advances in the development of vaccines against Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961961-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Global epidemiology of meningococcal disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961961-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Serogroup B meningococcal vaccines-an unfinished story

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961961-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961961-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A universal vaccine for serogroup B meningococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961961-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961961-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961961-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961961-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961961-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961961-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961961-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Investigation on the effect of immune selection on resistance to bactericidal antibodies to group B meningococci in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961961-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961961-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961961-8

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961961-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961961-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961961-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961961-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular targets in meningococci: efficient routine characterization and optimal outbreak investigation in conjunction with routine surveillance of the meningococcal group B vaccine candidate, fHBP

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961961-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Current status of pneumococcal vaccines: lessons to be learned and new insights

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961961-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Meningococcal Meningitis: Unprecedented Incidence of Serogroup X--Related Cases in 2006 in Niger

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961961-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961961-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961961-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Post-marketing safety monitoring of a new group B meningococcal vaccine in New Zealand, 2004-2006

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961961-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies on convulsive disorders in young children. I. Incidence of febrile and nonfebrile convulsions by age and other factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961961-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Kawasaki syndrome in Denmark.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961961-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased detection rate of Kawasaki disease using new diagnostic algorithm, including early use of echocardiography.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961961-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(12)61961-8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23324563%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23324563%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40260742&oldid=1891220552"